Zuzanna Zalewska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zuzanna Zalewska has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Lesiak
Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Pomorska Street 251, 92-213 Lodz, Poland
1 shared publication - Dorota Sobolewska-Sztychny
Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Pomorska Street 251, 92-213 Lodz, Poland
1 shared publication - Joanna Narbutt
Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Pomorska Street 251, 92-213 Lodz, Poland
1 shared publication - Natalia Bien
International Doctoral School, Medical University of Lodz, Hallera 1 Square, 90-647 Lodz, Poland
1 shared publication - Patryk Cegiełka
Central Clinical Hospital of the Medical University of Łódź, ul. Pomorska 251 92-213 Łódź, Poland
1 shared publication - Wiktoria Lisińska
Department of Nephrocardiology, Medical University of Lodz, 90-419 Lodz, Poland
1 shared publication
Latest Publications
- Open Access
- 9 July 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (14) , 6592
Gene Therapies in Dermatological Diseases: A Breakthrough in Treatment
Gene therapy involves introducing genetic material into cells to treat or prevent disease and offers highly targeted and potentially curative approaches for both inherited and acquired conditions. The skin is an especially suitable organ for gene therapy due to its accessibility, ease of sampling, rapid cell turnover, and the possibility for localized treatment with minimal systemic exposure. Gene therapy is being actively explored across a range of dermatological conditions, including recessive dystrophic epidermolysis bullosa, ichthyosis, psoriasis, chronic wounds, and melanoma, with therapeutic strategies encompassing viral vectors, non-viral delivery systems, gene editing technologies, RNA-based treatments, and cell-based approaches. These diverse methods aim to correct genetic defects, modulate immune responses, promote tissue repair, or selectively target malignant cells. This review examines the advancements and potential of gene therapies in addressing complex skin diseases, providing hope for improved patient outcomes and long-term care.
- 9 July 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (14) , 6592
Open AccessGene Therapies in Dermatological Diseases: A Breakthrough in Treatment
Gene therapy involves introducing genetic material into cells to treat or prevent disease and offers highly targeted and potentially curative approaches for both inherited and acquired conditions. The skin is an especially suitable organ for gene therapy due to its accessibility, ease of sampling, rapid cell turnover, and the possibility for localized treatment with minimal systemic exposure. Gene therapy is being actively explored across a range of dermatological conditions, including recessive dystrophic epidermolysis bullosa, ichthyosis, psoriasis, chronic wounds, and melanoma, with therapeutic strategies encompassing viral vectors, non-viral delivery systems, gene editing technologies, RNA-based treatments, and cell-based approaches. These diverse methods aim to correct genetic defects, modulate immune responses, promote tissue repair, or selectively target malignant cells. This review examines the advancements and potential of gene therapies in addressing complex skin diseases, providing hope for improved patient outcomes and long-term care.